Keywords: crucell, quinvaxem, gets, who, prequalification, dutch, biotechnology

Crucell's Quinvaxem gets WHO prequalification

Article | 02 October 2006

Dutch biotechnology firm Crucell NV says that Quinvaxem, its fully-liquid pentavalent vaccine against five important childhood diseases: diphtheria, tetanus, pertussis, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Tetanus

Tetanus Toxoid

Go to drug listing